Tag: Fane tower
I-195 Commission to pitch Parcel 42 to Hasbro
PROVIDENCE – The I-195 Redevelopment District Commission is asking the board of directors to approve the designation of a vacant parcel of district land...
Five Questions With: Brent Runyon
Now that you’ve stepped down, what accomplishments are you most proud of in the decade you led the preservation society?
It’s been a long...
With Fane Tower out, leaders mull over what should go on...
After years under contract with an out-of-state developer, Parcel 42 on the former Interstate 195 land in Providence is finally up for grabs again....
Most-read stories on PBN.com, March 2023
1. Cannabis company buys Warwick restaurant building for $2.25M POSTED ONLINE: MARCH 9 The vacant restaurant building that previously was the home of Agaves Mexican Grill...
No winners in lengthy Fane saga
The Fane Tower saga is mercifully over in Providence, leaving both the city and developer bruised in the seven-year process.
In the end, it wasn’t...
Developer declares Fane Tower project dead
PROVIDENCE - The Fane Tower saga has officially ended.
The New York-based Fane Organization announced Friday it will no longer proceed with the development of...
Brown’s land of opportunity: University’s expansion is welcomed but is school...
Olin Thompson’s Jewelry District walking tour begins at the corner of Richmond and Ship streets in Providence, on a plaza covered in stepped, wooden...
I-195 commission to consider another extension for Fane Tower
PROVIDENCE – The long-winded saga of the controversial Fane Tower project might be far from approaching its finish line, as the I-195 Redevelopment District...
195 district commission is shifting its development focus
The I-195 Redevelopment District Commission turns 12 years old this year, and its leaders agree: it’s time for a change of direction.
After contributing to...
Most-read stories on PBN.com, January 2023
1. Lifespan announces ‘breakthrough’ in brain cancer research POSTED ONLINE: JAN. 6. Lifespan Cancer Institute researchers said the phase 3 trial of the DCVax-L vaccine showed...
- Featured Event -
